Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (25)

2016

  1. Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 8, pp. 743-753

  2. Personality traits in patients with cluster headache: a comparison with migraine patients

    Journal of Headache and Pain, Vol. 17, Núm. 1

2014

  1. Frontal gamma noise power and cognitive domains in schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 221, Núm. 1, pp. 104-113

  2. Gamma power and cognition in patients with schizophrenia and their first-degree relatives

    Neuropsychobiology, Vol. 69, Núm. 2, pp. 120-128

2013

  1. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

  2. Spatial distribution and cognitive correlates of gamma noise power in schizophrenia

    Psychological Medicine, Vol. 43, Núm. 6, pp. 1175-1185

2012

  1. Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 38, Núm. 2, pp. 270-275

2005

  1. Dorsolateral prefrontal cortex contribution to abnormalities of the P300 component of the event-related potential in schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 140, Núm. 1, pp. 17-26

2004

  1. An electrophysiological (ERP) component, the recognition potential, in the assessment of brain semantic networks in patients with schizophrenia

    Schizophrenia Research, Vol. 71, Núm. 2-3, pp. 393-404

  2. Long-term olanzapine treatment and P300 parameters in Schizophrenia

    Neuropsychobiology, Vol. 50, Núm. 2, pp. 182-188

2001

  1. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients

    Psychiatry Research, Vol. 101, Núm. 1, pp. 75-81

  2. El componente P300 de los potenciales evocados en la valoración de la esquizofrenia: Nuevas evidencias y visiones de futuro

    Revista de Neurologia, Vol. 32, Núm. 3, pp. 250-258

  3. P300 amplitude as a possible correlate of frontal degeneration in schizophrenia

    Schizophrenia Research, Vol. 49, Núm. 1-2, pp. 121-128

1998

  1. Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia

    Psychiatry Research, Vol. 77, Núm. 1, pp. 21-28

1997

  1. Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPET study

    Schizophrenia Research, Vol. 25, Núm. 1, pp. 11-20

  2. Fronto-striato-thalamic perfusion and clozapine response in treatment- refractory schizophrenic patients. A 99mTc-HMPAO study

    Psychiatry Research - Neuroimaging, Vol. 76, Núm. 1, pp. 51-61

  3. The Wisconsin Card Sorting Test and the assessment of frontal function: A validation study with event related potentials

    Neuropsychologia, Vol. 35, Núm. 4, pp. 399-408

1996

  1. Perfusion cerebral regional y respuesta a la clozapina en la esquizofrenia resistente al tratamiento

    Revista Espanola de Medicina Nuclear, Vol. 15, Núm. 5, pp. 317-324

  2. SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine

    American Journal of Psychiatry, Vol. 153, Núm. 10, pp. 1343-1346

1995

  1. Cerebral perfusion, electrical activity and effects of serotonergic treatment in obsessive-compulsive disorder: A preliminary study

    Neuropsychobiology, Vol. 32, Núm. 3, pp. 139-148